Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Sign in!
Subscribe
Clinical Topics
View All
Addiction
ADHD
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Webcast
Recent JCP Articles on Webcast
JCP
ASCP Corner
What Clinicians Should Know About the Pragmatic Use of Xanomeline-Trospium Combination
June 9, 2025
This article will help familiarize clinicians with practical issues in the use of xanomeline-trospium and its entry into the pharmacopoeia for schizophrenia.
Joseph F. Goldberg
,
Peter J. Weiden
JCP
Case Report
Administering Semaglutide With Long-Term Olanzapine Use
June 9, 2025
This report describes use of the GLP-1R agonist semaglutide in a patient with schizophrenia and severe, olanzapine-induced weight gain that was resistant to alternative treatments.
Francesca L. Ricciardi
,
Jayda L. Melnitsky
,
Shannon B. Peleg
, et al
JCP
Insights
The Dopamine-3 Receptor in the Treatment of Schizophrenia: Part 1
June 6, 2025
In Part I of his video, Dr. Ragy Girgis highlights the D3 receptor as a promising target in schizophrenia, with potential to address negative and cognitive symptoms unmet by...
Ragy Girgis
Recent PCC Articles on Webcast
PCC
Case Report
Recognizing Cotard Syndrome in the ED
June 12, 2025
Cotard syndrome can increase a patient’s risk for self-harm, self-starvation, and suicide, so it is imperative that early recognition occurs, especially in the ED.
Ashish Sharma
,
Monica A. Nava Frenier
,
Jeana Benton
PCC
Review Article
Efficacy of GLP-1 Agonists in Mental Disorders
June 10, 2025
Current evidence underscores the potential of GLP-1 receptor agonists as a novel therapeutic approach for certain psychiatric disorders, particularly AUDs, depression, and autism-related food behaviors.
Mohsan Ali
,
Ayesha Ahmed
,
Basim Ahmed Khan
, et al
PCC
Case Report
β-blocker/Colchicine Coingestion With Cocaine Intoxication
June 5, 2025
The authors describe a case in which cocaine-induced cardiac toxicity initially masked β-blocker (carvedilol) toxicity and suggest improvements in management for similar cases.
Olivia Levine
,
Souparno Mitra
Featured
Webcast Research
news
Can Cariprazine Offer a Less Sleepy Schizophrenia Treatment?
June 11, 2025
A pair of studies suggest that dopamine partial agonists like cariprazine might reduce sedation and sleep aid use in schizophrenia patients.
news
Physician End-of-Life Preferences Expose Stark Differences
June 10, 2025
Research reveals that while most physicians prefer end-of-life comfort over life-extending measures for themselves, their views vary widely.
news
How Patients Talk May Matter More Than What They Say
June 9, 2025
A new study suggests that subtle language cues in how patients talk about their mental health may reveal critical, often overlooked insights.